Duration Of Monotherapy

Duration of Monotherapy is a temporal metric denoting the length of time during which a single therapeutic agent is administered as the sole treatment for a condition, distinguishing it from combination or sequential therapies.

81

Publications

5K

Citations

718

Authors

332

Institutions

Publications per year

2017–2026

19

Authors

718

  1. HA
    Haya Ascher‐Svanum

    Eli Lilly (United States), United States

    2 publications · 195 citations

    2

    h-index

  2. SS
    Shashikant Srivastava

    Baylor University Medical Center, United States

    2 publications · 68 citations

    2

    h-index

  3. TG
    Tawanda Gumbo

    Baylor University Medical Center, United States

    2 publications · 68 citations

    2

    h-index

  4. MJ
    Martin-Lorente Jl

    1 publications · 14 citations

    1

    h-index

  5. LG
    Lucy Gong

    The University of Texas MD Anderson Cancer Center, United States

    1 publications · 36 citations

    1

    h-index

1–5 of 718

Venues

  1. PubMed

    Repository · 7 publications · 210 citations

    7

    h-index

  2. Journal of Antimicrobial Chemotherapy

    JAC · 3 publications · 180 citations

    3

    h-index

  3. The Journal of Clinical Psychiatry

    3 publications · 536 citations

    3

    h-index

  4. Epilepsia

    3 publications · 239 citations

    3

    h-index

  5. The Journal of Infectious Diseases

    JID · 2 publications · 152 citations

    2

    h-index

1–5